Developer docs
API playgroundTry for free, no card

Search company profiles

Hanway Associates

Full company profile

uuid000ufmh

Namestring
Hanway Associates
Legal namestring
Hanway Associates Limited
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Hanway Associates is a London-based strategy and corporate advisory firm focused exclusively on the European cannabis sector. Founded in 2017 and operating as Hanway Associates Limited (incorporated in England & Wales), the firm serves startups, FMCG companies, governments and investors with services spanning corporate strategy, M&A advisory, regulatory licensing support, and market intelligence. The firm employs between 11 and 50 people and has no public revenue disclosure.

The company's offering is structured as an interconnected ecosystem across four main entities: Hanway Associates (the core advisory practice); First Wednesdays, a 4,500+-member investor and entrepreneur network launched in 2018 that also publishes proprietary market reports; The Hanway Company, a venture studio housing regulated cannabis-adjacent startups; and CROP17, a joint venture with Savills, CambridgeHOK and Subrosa providing turnkey planning, build and operations services for cannabis facilities. Revenue is generated through professional services fees (strategy retainers, M&A success fees, licensing mandates), report-related revenue and venture studio economics. Distribution is sales-led and community-led, supported by content marketing (research reports, a newsletter), a strategic PR partnership with Pagefield, and monthly First Wednesdays events across London, Paris and Amsterdam.

Underlying delivery is human-capital-intensive: the firm has no proprietary technology platform and no AI/ML capability disclosed. Competitive advantage is built on cross-jurisdictional regulatory expertise (e.g., facilitating the first British Isles commercial cannabis supply licence since GW Pharmaceuticals for Northern Leaf), the scale of its First Wednesdays network, and partnerships with institutional backers including DLA Piper, Crunchbase, Hannam & Partners, the Danish Ministry of Foreign Affairs, and Pagefield. The firm is privately held, founder-led, and headquartered at 120 Aldersgate Street, London.

Short descriptiontext

Hanway Associates is a London-based strategy and M&A advisory firm founded in 2017 that helps startups, FMCG companies, governments and investors navigate the European cannabis sector, operating alongside the First Wednesdays network, The Hanway Company venture studio and the CROP17 facility solutions JV.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cannabis advisory services, strategy consulting, M&A advisory, regulatory licensing support, market research reports
NAICS code3 codes
  • Management Consulting Services54161
  • Marketing Consulting Services541613
  • Portfolio Management and Investment Advice523940
SIC code1 code
  • Services-Management Consulting Services8742
Product category
Cannabis Sector Advisory
Social media profiles1 record
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model5 records
1Strategy Advisory
TypeProfessional Services
Description

Strategy consulting services helping companies launch, build and grow in new cannabis markets. Includes market entry support, corporate strategy, and regulatory guidance.

hanwayassociates.com
2M&A Advisory
TypeProfessional Services
Description

Deal advisory and transaction support for mergers and acquisitions in the cannabis sector.

hanwayassociates.com
3Research Reports
TypeProfessional Services
Description

Market research reports including Recreational Europe, European Investment Ecosystem, and European Medical Ecosystem. Reports are available for download and provide market intelligence for investors, entrepreneurs and policymakers.

hanwayassociates.com
4Licensing Support
TypeProfessional Services
Description

Structured and strategic licensing support for companies navigating the Home Office controlled drugs licensing process for research purposes or production of cannabis-based medicinal products.

hanwayassociates.com
5Venture Operations
TypeManaged Services
Description

The Hanway Company venture studio with portfolio of complex and highly regulated startups and service businesses. CROP17 provides end-to-end service for those looking to enter cannabis markets.

hanwayassociates.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Technology or R&D
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Hanway Associates provides strategy consulting and M&A advisory services for the European cannabis sector, helping startups, FMCG companies, governments, and investors launch, build, and grow in new cannabis markets. Offerings include corporate strategy, deal advisory, regulatory licensing support (including UK Home Office controlled drugs licensing), and proprietary market research reports covering recreational, medical, and investment ecosystem topics. The firm also operates the First Wednesdays investor/entrepreneur network (4,500+ members) and The Hanway Company venture studio with the CROP17 turnkey facility subsidiary.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • First cannabis licence in British Isles in 20 years facilitated for Northern Leaf
+2 more records
Product overview1 text field

Hanway Associates is Europe's leading cannabis advisory firm offering a portfolio of interconnected services. The core offering comprises strategic advisory and M&A consulting for the cannabis sector (Hanway Associates), a membership network with market intelligence reports (First Wednesdays with 4,500+ members), and a venture studio (The Hanway Company) managing a portfolio of regulated startups. Key sub-brands include CROP17 (turnkey cannabis facility development solution) and a series of market research reports covering recreational, medical, and investment ecosystem topics. Services span strategy, deal advisory, licensing assistance, market research, and regulatory compliance for startups, FMCG companies, governments, and investors.

Product and service8 records
1Hanway Associates Advisory Services
CategoryStrategy and M&A Advisory
Description

Strategy consulting and M&A advisory services for the cannabis sector, helping startups, FMCG companies, governments, and investors launch, build, and grow in new European markets. Includes corporate strategy, deal advisory, and regulatory guidance.

2Licensing Support Services
CategoryRegulatory Licensing Support
Description

Structured and strategic licensing support for companies navigating the UK Home Office controlled drugs licensing process for cannabis research or production of cannabis-based medicinal products.

3First Wednesdays Network
CategoryIndustry Network and Market Intelligence
Description

Network of 4,500+ members across Europe providing market reports and commercial connections for the cannabis sector. Publishes first-of-a-kind reports backed by interviews, new data, and public polling on cannabis market catalysts.

4The Hanway Company (Venture Studio)
CategoryVenture Studio
Description

Venture studio with a portfolio of complex and highly regulated startups and service businesses operating in the cannabis and emerging sectors.

5CROP17 Turnkey Facility Solution
CategoryFacility Development and Operations
Description

Turnkey solution for planning, building, and operating cannabis facilities. Provides end-to-end services including cultivation design, construction, licensing support, and operational expertise through partnerships with Savills, CambridgeHOK, and Subrosa.

6Recreational Europe Report
CategoryMarket Research Report
Description

Report exploring cannabis legalisation across Europe, comparing the trajectory to US legalisation in 2012, examining lessons from North American markets, and forecasting where reform might happen next.

7European Cannabis Investment Ecosystem (ECIE) Report
CategoryMarket Research Report
Description

Report examining EU-wide venture capital and retail investments in cannabis, documenting major corporates and institutional investors entering the sector. Produced in partnership with DLA Piper, Enexis, Hannam & Partners, Crunchbase, and Seedrs.

8European Medical Ecosystem Report
CategoryMarket Research Report
Description

Report highlighting key players and emerging trends in Europe's medical cannabis ecosystem, with insights into market formation and evolution. Produced in collaboration with Invest in Denmark (Danish Ministry of Foreign Affairs).

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership18 partners
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2022-09-08
Description

Collaboration with advanced analytical laboratory based in Denmark to produce technical briefing on transparency in non-transparent cannabis markets and pharmaceutical standards.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2022-07-11
Description

Collaboration on 'Failure to Launch' report examining Canadian excise tax reform with #Stand For Craft campaign.

Strategic tierCoreTypeGTM or Marketing PartnerAnnounced on2022-06-14
Description

Strategic partnership with independent PR and public affairs consultancy to create full-service consultancy offer for businesses looking to operate in the emerging European cannabis sector. Partnership offers services from traditional PR and public affairs through to business consultancy and M&A support.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2022-04-29
Description

International law and business services firm collaborated on Considerations for Legalisation blog series exploring legal, political, financial and public safety perspectives.

5Crunchbase
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2022-04-01
Description

Partnership for European Investment Ecosystem report providing investment data and market intelligence on cannabis sector investments.

hanwayassociates.com
6DLA Piper
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2021-07-01
Description

Partnership with global law firm for European Cannabis Investment Ecosystem (ECIE) report examining scope and scale of major EU-wide investments.

hanwayassociates.com
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2021-07-01
Description

Swedish cannabis fund partner for European Investment Ecosystem report providing data and analysis on European cannabis investment landscape.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2021-07-01
Description

London-based investment bank partner for European Investment Ecosystem report providing investment analysis.

Strategic tierMinorTypeImplementation/ SI/ Consulting PartnerAnnounced on2021-01-12
Description

Licensing assistance provided to Jersey's first medical cannabis cultivator for navigating controlled drugs licensing process.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2020-11-03
Description

Co-authored report on medical cannabis market across Europe producing new market sizing figures and identifying winning strategies for operators.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2020-06-01
Description

Part of Danish Ministry of Foreign Affairs collaborated on European Medical Ecosystem report with deep dive into country's commercial model.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-02-27
Description

CROP17 joint venture bringing together Savills, Cambridge HOK, Subrosa and Hanway to provide end-to-end service for those looking to enter cannabis markets including cultivation opportunities.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-02-27
Description

CROP17 joint venture partner providing greenhouse and cultivation expertise for cannabis market entry services.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-02-27
Description

CROP17 joint venture partner for cannabis market entry and cultivation services.

15Volteface
Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2020-01-01
Description

Partnership with think tank for weekly video blog 'All Good Points' providing cannabis insights and analysis.

hanwayassociates.com
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2019-11-01
Description

Partnership for Dutch regulated cannabis cultivation experiment tender application.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2018-01-01
Description

UK crowdfunding platform partner providing data for European Investment Ecosystem report on retail investor participation in cannabis sector.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2017-04-10
Description

White paper 'Into The Light' on Greenhouse Cannabis Cultivation in British Columbia examining market opportunity, greenhouse advantages and policy guidance.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Viridian Capital Advisors
TypeDirect peer
Description

US-based cannabis-focused investment bank and advisory firm providing M&A, capital raising, and strategic advisory to cannabis companies. Directly comparable to Hanway's M&A and strategy advisory services within the cannabis sector.

TypeBroad incumbent
Description

Major global cannabis operator with interests in European medical cannabis and cannabinoid products. Comparable as a significant European cannabis market participant, though operating as an operator/investor rather than advisory firm.

TypeDirect peer
Description

UK-based cannabis-focused research and advisory firm publishing market intelligence reports and industry events. Directly comparable to Hanway as a European cannabis advisory/research specialist serving investors and operators with similar research products and consulting services.

TypeDirect peer
Description

Cannabis-focused data analytics and market intelligence firm providing reports, datasets, and consulting to operators and investors. Comparable to Hanway's research report products and investor advisory.

TypeDirect peer
Description

US-based cannabis market research and consulting firm that co-authored the European Medical Ecosystem report with Hanway. Comparable as a cannabis-specialist research/consulting firm with similar product-market fit and customer base.

6DLA Piper
TypeOthers
Description

Global law firm that partnered with Hanway on the European Investment Ecosystem report. Adjacent comparator as a global professional services firm with overlapping cannabis client base and regulatory expertise, though much broader in scope.

TypeBroad incumbent
Description

Canadian investment bank with a dedicated cannabis research coverage and capital markets advisory practice. Comparable to Hanway's M&A advisory services for cannabis, but operating at a larger scale with broader financial services activities.

8Volteface
TypeEmerging player
Description

UK cannabis policy think tank that partners with Hanway on the 'All Good Points' video blog. Adjacent comparator as a cannabis-focused policy/advocacy organization with overlapping ecosystem positioning.

TypeBroad incumbent
Description

Large multi-state cannabis operator with European presence that Hanway reportedly partners with. Comparable as a major European cannabis market participant, though operating as a vertically integrated operator rather than an advisor.

TypeOthers
Description

Cannabis policy reform organizations operating in Europe and the US. Related comparator as ecosystem participants addressing the same regulatory and reform issues Hanway advises on, though operating as advocacy rather than commercial advisory.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Hanway Associates

Cannabis Sector Advisoryhanwayassociates.com

Hanway Associates is a London-based strategy and M&A advisory firm founded in 2017 that helps startups, FMCG companies, governments and investors navigate the European cannabis sector, operating alongside the First Wednesdays network, The Hanway Company venture studio and the CROP17 facility solutions JV.

What Hanway Associates does

Hanway Associates is a London-based strategy and corporate advisory firm focused exclusively on the European cannabis sector. Founded in 2017 and operating as Hanway Associates Limited (incorporated in England & Wales), the firm serves startups, FMCG companies, governments and investors with services spanning corporate strategy, M&A advisory, regulatory licensing support, and market intelligence. The firm employs between 11 and 50 people and has no public revenue disclosure.

The company's offering is structured as an interconnected ecosystem across four main entities: Hanway Associates (the core advisory practice); First Wednesdays, a 4,500+-member investor and entrepreneur network launched in 2018 that also publishes proprietary market reports; The Hanway Company, a venture studio housing regulated cannabis-adjacent startups; and CROP17, a joint venture with Savills, CambridgeHOK and Subrosa providing turnkey planning, build and operations services for cannabis facilities. Revenue is generated through professional services fees (strategy retainers, M&A success fees, licensing mandates), report-related revenue and venture studio economics. Distribution is sales-led and community-led, supported by content marketing (research reports, a newsletter), a strategic PR partnership with Pagefield, and monthly First Wednesdays events across London, Paris and Amsterdam.

Underlying delivery is human-capital-intensive: the firm has no proprietary technology platform and no AI/ML capability disclosed. Competitive advantage is built on cross-jurisdictional regulatory expertise (e.g., facilitating the first British Isles commercial cannabis supply licence since GW Pharmaceuticals for Northern Leaf), the scale of its First Wednesdays network, and partnerships with institutional backers including DLA Piper, Crunchbase, Hannam & Partners, the Danish Ministry of Foreign Affairs, and Pagefield. The firm is privately held, founder-led, and headquartered at 120 Aldersgate Street, London.

Hanway Associates firmographics

Firmographics
Name
Hanway Associates
Legal name
Hanway Associates Limited
Website
https://hanwayassociates.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
1–10 employees
Short description
Hanway Associates is a London-based strategy and M&A advisory firm founded in 2017 that helps startups, FMCG companies, governments and investors navigate the European cannabis sector, operating alongside the First Wednesdays network, The Hanway Company venture studio and the CROP17 facility solutions JV.
Ownership category
akta.pro rank

Where Hanway Associates is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

Hanway Associates business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

  1. Strategy Advisory: Strategy consulting services helping companies launch, build and grow in new cannabis markets. Includes market entry support, corporate strategy, and regulatory guidance.
  2. M&A Advisory: Deal advisory and transaction support for mergers and acquisitions in the cannabis sector.
  3. Research Reports: Market research reports including Recreational Europe, European Investment Ecosystem, and European Medical Ecosystem. Reports are available for download and provide market intelligence for investors, entrepreneurs and policymakers.
  4. Licensing Support: Structured and strategic licensing support for companies navigating the Home Office controlled drugs licensing process for research purposes or production of cannabis-based medicinal products.
  5. Venture Operations: The Hanway Company venture studio with portfolio of complex and highly regulated startups and service businesses. CROP17 provides end-to-end service for those looking to enter cannabis markets.

Go-to-market motion3 records

Distribution channels2 records

Marketing channels6 records

Hanway Associates product offering

Product offering

Core offering

Hanway Associates provides strategy consulting and M&A advisory services for the European cannabis sector, helping startups, FMCG companies, governments, and investors launch, build, and grow in new cannabis markets. Offerings include corporate strategy, deal advisory, regulatory licensing support (including UK Home Office controlled drugs licensing), and proprietary market research reports covering recreational, medical, and investment ecosystem topics. The firm also operates the First Wednesdays investor/entrepreneur network (4,500+ members) and The Hanway Company venture studio with the CROP17 turnkey facility subsidiary.

Product overview

Hanway Associates is Europe's leading cannabis advisory firm offering a portfolio of interconnected services. The core offering comprises strategic advisory and M&A consulting for the cannabis sector (Hanway Associates), a membership network with market intelligence reports (First Wednesdays with 4,500+ members), and a venture studio (The Hanway Company) managing a portfolio of regulated startups. Key sub-brands include CROP17 (turnkey cannabis facility development solution) and a series of market research reports covering recreational, medical, and investment ecosystem topics. Services span strategy, deal advisory, licensing assistance, market research, and regulatory compliance for startups, FMCG companies, governments, and investors.

Differentiator

Problem solved

Functional benefit

Products and services

  • Hanway Associates Advisory Services Strategy consulting and M&A advisory services for the cannabis sector, helping startups, FMCG companies, governments, and investors launch, build, and grow in new European markets. Includes corporate strategy, deal advisory, and regulatory guidance.
  • Licensing Support Services Structured and strategic licensing support for companies navigating the UK Home Office controlled drugs licensing process for cannabis research or production of cannabis-based medicinal products.
  • First Wednesdays Network Network of 4,500+ members across Europe providing market reports and commercial connections for the cannabis sector. Publishes first-of-a-kind reports backed by interviews, new data, and public polling on cannabis market catalysts.
  • The Hanway Company (Venture Studio) Venture studio with a portfolio of complex and highly regulated startups and service businesses operating in the cannabis and emerging sectors.
  • CROP17 Turnkey Facility Solution Turnkey solution for planning, building, and operating cannabis facilities. Provides end-to-end services including cultivation design, construction, licensing support, and operational expertise through partnerships with Savills, CambridgeHOK, and Subrosa.
  • Recreational Europe Report Report exploring cannabis legalisation across Europe, comparing the trajectory to US legalisation in 2012, examining lessons from North American markets, and forecasting where reform might happen next.
  • European Cannabis Investment Ecosystem (ECIE) Report Report examining EU-wide venture capital and retail investments in cannabis, documenting major corporates and institutional investors entering the sector. Produced in partnership with DLA Piper, Enexis, Hannam & Partners, Crunchbase, and Seedrs.
  • European Medical Ecosystem Report Report highlighting key players and emerging trends in Europe's medical cannabis ecosystem, with insights into market formation and evolution. Produced in collaboration with Invest in Denmark (Danish Ministry of Foreign Affairs).

Quantifiable outcome

  • First cannabis licence in British Isles in 20 years facilitated for Northern Leaf
  • +2 more outcomes

Companies that use Hanway Associates

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Hanway Associates technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Hanway Associates partnerships and signals

Strategic signal

Partnerships

18 partnerships are on record, tiered minor and core.

  • QNTM LabsminorStrategic or Co-development Partner · 8 September 2022Collaboration with advanced analytical laboratory based in Denmark to produce technical briefing on transparency in non-transparent cannabis markets and pharmaceutical standards.
  • Tantalus LabsminorStrategic or Co-development Partner · 11 July 2022Collaboration on 'Failure to Launch' report examining Canadian excise tax reform with #Stand For Craft campaign.
  • PagefieldcoreGTM or Marketing Partner · 14 June 2022Strategic partnership with independent PR and public affairs consultancy to create full-service consultancy offer for businesses looking to operate in the emerging European cannabis sector. Partnership offers services from traditional PR and public affairs through to business consultancy and M&A support.
  • InceminorStrategic or Co-development Partner · 29 April 2022International law and business services firm collaborated on Considerations for Legalisation blog series exploring legal, political, financial and public safety perspectives.
  • CrunchbaseminorStrategic or Co-development Partner · 1 April 2022Partnership for European Investment Ecosystem report providing investment data and market intelligence on cannabis sector investments.
  • DLA PiperminorStrategic or Co-development Partner · 1 July 2021Partnership with global law firm for European Cannabis Investment Ecosystem (ECIE) report examining scope and scale of major EU-wide investments.
  • EnexisminorStrategic or Co-development Partner · 1 July 2021Swedish cannabis fund partner for European Investment Ecosystem report providing data and analysis on European cannabis investment landscape.
  • Hannam & PartnersminorStrategic or Co-development Partner · 1 July 2021London-based investment bank partner for European Investment Ecosystem report providing investment analysis.
  • Northern LeafminorImplementation/ SI/ Consulting Partner · 12 January 2021Licensing assistance provided to Jersey's first medical cannabis cultivator for navigating controlled drugs licensing process.
  • Brightfield GroupminorStrategic or Co-development Partner · 3 November 2020Co-authored report on medical cannabis market across Europe producing new market sizing figures and identifying winning strategies for operators.
  • Invest in DenmarkminorStrategic or Co-development Partner · 1 June 2020Part of Danish Ministry of Foreign Affairs collaborated on European Medical Ecosystem report with deep dive into country's commercial model.
  • SavillscoreStrategic or Co-development Partner · 27 February 2020CROP17 joint venture bringing together Savills, Cambridge HOK, Subrosa and Hanway to provide end-to-end service for those looking to enter cannabis markets including cultivation opportunities.
  • CambridgeHOKcoreStrategic or Co-development Partner · 27 February 2020CROP17 joint venture partner providing greenhouse and cultivation expertise for cannabis market entry services.
  • SubrosacoreStrategic or Co-development Partner · 27 February 2020CROP17 joint venture partner for cannabis market entry and cultivation services.
  • VoltefaceminorGTM or Marketing Partner · 1 January 2020Partnership with think tank for weekly video blog 'All Good Points' providing cannabis insights and analysis.
  • BlumeminorStrategic or Co-development Partner · 1 November 2019Partnership for Dutch regulated cannabis cultivation experiment tender application.
  • SeedrsminorStrategic or Co-development Partner · 1 January 2018UK crowdfunding platform partner providing data for European Investment Ecosystem report on retail investor participation in cannabis sector.
  • Tantalus LabsminorStrategic or Co-development Partner · 10 April 2017White paper 'Into The Light' on Greenhouse Cannabis Cultivation in British Columbia examining market opportunity, greenhouse advantages and policy guidance.

Scale indicators4 records

Recent moves7 records

Expansion highlights6 records

Hanway Associates competitors and assessment

Company assessment

Direct peers

  • Viridian Capital Advisors: US-based cannabis-focused investment bank and advisory firm providing M&A, capital raising, and strategic advisory to cannabis companies. Directly comparable to Hanway's M&A and strategy advisory services within the cannabis sector.
  • Prohibition Partners: UK-based cannabis-focused research and advisory firm publishing market intelligence reports and industry events. Directly comparable to Hanway as a European cannabis advisory/research specialist serving investors and operators with similar research products and consulting services.
  • New Frontier Data: Cannabis-focused data analytics and market intelligence firm providing reports, datasets, and consulting to operators and investors. Comparable to Hanway's research report products and investor advisory.
  • Brightfield Group: US-based cannabis market research and consulting firm that co-authored the European Medical Ecosystem report with Hanway. Comparable as a cannabis-specialist research/consulting firm with similar product-market fit and customer base.

Broad incumbents

  • Canopy Growth Corporation: Major global cannabis operator with interests in European medical cannabis and cannabinoid products. Comparable as a significant European cannabis market participant, though operating as an operator/investor rather than advisory firm.
  • ATB Capital Markets: Canadian investment bank with a dedicated cannabis research coverage and capital markets advisory practice. Comparable to Hanway's M&A advisory services for cannabis, but operating at a larger scale with broader financial services activities.
  • Curaleaf International: Large multi-state cannabis operator with European presence that Hanway reportedly partners with. Comparable as a major European cannabis market participant, though operating as a vertically integrated operator rather than an advisor.

Others

  • DLA Piper: Global law firm that partnered with Hanway on the European Investment Ecosystem report. Adjacent comparator as a global professional services firm with overlapping cannabis client base and regulatory expertise, though much broader in scope.
  • Marijuana Policy Project (MPP) / European policy orgs: Cannabis policy reform organizations operating in Europe and the US. Related comparator as ecosystem participants addressing the same regulatory and reform issues Hanway advises on, though operating as advocacy rather than commercial advisory.

Emerging players

  • Volteface: UK cannabis policy think tank that partners with Hanway on the 'All Good Points' video blog. Adjacent comparator as a cannabis-focused policy/advocacy organization with overlapping ecosystem positioning.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Hanway Associates social profiles

Digital presence

Hanway Associates financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Hanway Associates leadership team

Management profile

Number of profiles

Profiles5 records

Hanway Associates subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

Hanway Associates funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Hanway Associates M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hanway Associates

What does Hanway Associates do?

Hanway Associates provides strategy consulting and M&A advisory services for the European cannabis sector, helping startups, FMCG companies, governments, and investors launch, build, and grow in new cannabis markets. Offerings include corporate strategy, deal advisory, regulatory licensing support (including UK Home Office controlled drugs licensing), and proprietary market research reports covering recreational, medical, and investment ecosystem topics. The firm also operates the First Wednesdays investor/entrepreneur network (4,500+ members) and The Hanway Company venture studio with the CROP17 turnkey facility subsidiary.

Is Hanway Associates a public or private company?

Hanway Associates is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Hanway Associates founded?

Hanway Associates was founded in 2017. It employs 1 to 10 people.

Where is Hanway Associates based?

Hanway Associates is headquartered in London, United Kingdom, in the Europe region.

How does Hanway Associates make money?

Five revenue lines are on record. Strategy Advisory is the primary driver. The others are M&A Advisory, research Reports, licensing Support and venture Operations.

Who are Hanway Associates's main competitors?

Direct peers on record are Viridian Capital Advisors, Prohibition Partners, New Frontier Data and Brightfield Group. Broad incumbents are Canopy Growth Corporation, ATB Capital Markets and Curaleaf International. Others are DLA Piper and Marijuana Policy Project (MPP) / European policy orgs. Volteface is listed as an emerging player.

Does Hanway Associates have an API?

No public API is recorded for Hanway Associates.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
BloombergBankers Are Circling Europe’s Growing Cannabis MarketInvestment bankers are increasing coverage of European cannabis companies, with Canaccord Genuity appointing a head of European cannabis investment banking. French bank Bryan Garnier & Co. and Jefferies Financial Group have also started covering the sector, signaling growing interest as European pot businesses grow.AgFunderNewsGrowing cannabis legally in the UK is hard, but far from impossibleThe UK's legal cannabis market is expanding after medical cannabis was legalized in 2018, with a CROP17 partnership between Hanway Associates, Savills, and CambridgeHOK to help build cultivation facilities. BDS Analytics forecasts the global legal cannabis industry to grow from £11.5 billion in 2019 to £35 billion by 2024, and UK prescriptions could rise to over 185,000 by 2023.ProactiveinvestorsHanway Associates CEO on 'explosion' of UK retail interest in CannabisHanway Associates CEO George McBride said a recent London cannabis thought leadership conference was well-attended, drawing foreign dignitaries, regulators, and investors. He noted that cannabis is now a popular topic with significant money in it, unlike a few years ago when it was difficult to discuss in the UK.The GuardianWhy legal weed in Britain may be a pipe dreamExperts say the UK is unlikely to legalize cannabis soon, despite 59% public support. The UK lacks the political levers and industry pressure seen in the US, and legalization polls lower when taxing is included. A shift may occur within two to three years as cannabis cafes and professionals become more visible.PR NewswireGlobal Cannabis Partnership Welcomes First European Member: Hanway AssociatesThe Global Cannabis Partnership (GCP) announced Hanway Associates as its first European member, bringing the total membership to 32. This expansion supports GCP's efforts to establish a global social responsibility framework and launch a European initiative in London. The move coincides with Luxembourg becoming the first European country to legalize recreational cannabis.Evening StandardBusiness focus: London’s green rush? The City tunes in to cannabisLondon investors are flocking to cannabis companies, with a Cannabis Invest UK conference held in Mayfair. Analysts predict the global market could reach $150 billion within two years, while CBD products remain legal. UK medicinal cannabis legalization could open further investment opportunities.The IndependentUK missing out on cannabis industry 'green rush' worth billions because of outdated policies, say expertsUK experts say the country is missing out on a cannabis industry opportunity worth billions due to outdated prohibition policies. They cite a potential European market growth to €56bn (£49bn) in a decade and note that Canada's legal framework has allowed its firms to lead. The UK is urged to catch up with other nations legalizing medical cannabis.PR NewswireMedical Cannabis: UK Must Keep Pace with Europe, Say Political and Industry LeadersHanway Associates is hosting Cannabis Europa, a major medical cannabis conference at The Barbican Centre in London on 22 May 2018, bringing together UK MPs, MEPs, business leaders, academics, and regulators to discuss the future of medical cannabis in Europe. The conference aims to position Europe as a global leader in medical cannabis regulation, addressing topics including doctor and patient education, EU versus local jurisdiction, and the role of the EMA. North American investors, including Canaccord Genuity as title sponsor, are reportedly eyeing the European market as attitudes toward medical cannabis shift across the continent.